C 72H 80O 4 ,monoclinic, P 121 / n 1(no. 14), a =10.3709(3) Å, b =23.2467(6) Å, c =25.1444(7) Å, b =92.660(1)°,Source of material 4.0 g(100 mmol) NaOH in 7mlwater and 7.58 g(10.2 mmol) p -tert-butylcalix [4]arene [1] were added under stirring to 50 ml DMSO.Tothis mixture, 7.39 g(43.2 mmol) of benzyl bromide were added at3 23 K.Stirringw asc ontinued for 3hat3 43 K. After cooling to room temperature, the reaction mixture was quenched with diluted hydrochloric acid. Extraction with chloroform, drying over sodium sulphate, evaporation of the solvent and recrystallization from acetonitrile/acetone (1:3, v / v )gave the title compound ascolorless needles (yield 49 %, m.p. 515-516 K).
DiscussionInthe title compound, the calixarene framework adopts apinchedcone conformation [2], which is anu sualb ehavior of disubstituted calix [4]arenes [3] rather thanatetrasubstituted calix[4]arene such ashere. Moreover, the interplanarangles,formed by the opposite phenyl rings, i.e. A/C(86.46(7)°) and B/D(4.8(1)°), indicate anasymmetric overall conformation. Bywayofcontrast, the title compound in the structure of its complex with acetonitrile and sodium iodide (1:1:1) wasfound almost in aperfect cone conformation suggesting environmentale ffects [4]. Corresponding to the hydrophobicn ature of the molecule, intermolecularc ontacts are restricted to weakvander Waals forces. Thus, the molecularassembly in the crystals tructure follows close-packing requirements.